| Field | Row 1 |
|---|---|
| adsh | 0001999371-25-005694 |
| cik | 949961 |
| name | INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ |
| sic | 6798 |
| countryba | US |
| stprba | TX |
| cityba | DALLAS |
| zipba | 75234 |
| bas1 | 1603 LBJ FREEWAY |
| bas2 | SUITE 800 |
| baph | 4685224200 |
| countryma | US |
| stprma | TX |
| cityma | DALLAS |
| zipma | 75234 |
| mas1 | 1603 LBJ FREEWAY |
| mas2 | SUITE 800 |
| countryinc | US |
| stprinc | NV |
| ein | 752615944 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 13:08:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ior-10q_033125_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001999371-25-005694 | 20241231 | Accounts Payable Current | USD | 0 | us-gaap/2025 | ||||
| 0001999371-25-005694 | 20240331 | Advisory Fee To Related Party | 29000.0000 | USD | 1 | 0001999371-25-005694 | |||
| 0001999371-25-005694 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 156000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Costs And Expenses | 95000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Earnings Per Share Diluted | 0.2900 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Earnings Per Share Diluted | 0.2400 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Interest Income Expense Nonoperating Net | 150000.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Unified Housing Foundation Inc; | ||
| 0001999371-25-005694 | 20250331 | Liabilities And Stockholders Equity | 122921000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Net Cash Provided By Used In Operating Activities | 147000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005694 | 20250331 | Net Income Loss | 989000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Notes And Loans Receivable Net Noncurrent | 11146000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Operating Income Loss | -95000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Stockholders Equity | -1749000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
| 0001999371-25-005694 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 4107131.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 4066178.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Assets | 122921000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Accounts Payable Current | 5000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Additional Paid In Capital Common Stock | 61955000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Advisory Fee To Related Party | 29000.0000 | USD | 1 | 0001999371-25-005694 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20241231 | Assets | 121927000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Interest Income Expense Nonoperating Net | 1223000.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005694 | 20240331 | Net Cash Provided By Used In Operating Activities | 552000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Other Receivables Net Current | 110481000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Other Receivables Net Current | 110481000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20240331 | Stockholders Equity | 118669000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Stockholders Equity | 58206000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20241231 | Treasury Stock Value | 1749000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 4107131.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Common Stock Shares Outstanding | 4066178.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | General And Administrative Expense | 12000.0000 | USD | 1 | us-gaap/2025 | Related Party Transaction= Related Party; | ||
| 0001999371-25-005694 | 20250331 | Income Tax Expense Benefit | 263000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Increase Decrease In Accounts Payable | 5000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Increase Decrease In Accounts Receivable Related Parties | 920000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Net Income Loss | 1178000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | |||
| 0001999371-25-005694 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001999371-25-005694 | 20250331 | Payments For Repurchase Of Common Stock | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005694 | 20241231 | Retained Earnings Accumulated Deficit | 61679000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20231231 | Stockholders Equity | 42000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005694 | 20250331 | Stockholders Equity | 61955000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005694 | 20250331 | Stockholders Equity | 42000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005694 | 20250331 | Stockholders Equity | 62668000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20250331 | Advisory Fee To Related Party | 27000.0000 | USD | 1 | 0001999371-25-005694 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20241231 | Cash And Cash Equivalents At Carrying Value | 9000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Cash And Cash Equivalents At Carrying Value | 156000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -35000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Common Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Interest Income Expense Nonoperating Net | 1586000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Interest Income Expense Nonoperating Net | 1347000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Interest Income Expense Nonoperating Net | 124000.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Unified Housing Foundation Inc; | ||
| 0001999371-25-005694 | 20231231 | Stockholders Equity | 61955000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005694 | 20231231 | Stockholders Equity | -947000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
| 0001999371-25-005694 | 20241231 | Stockholders Equity | 61955000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005694 | 20250331 | Treasury Stock Common Shares | 107497.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 4066178.0000 | shares | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Assets Current | 110781000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 147000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Common Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Common Stock Shares Issued | 4173675.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Income Tax Expense Benefit | 313000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Increase Decrease In Notes Receivable Related Parties | -73000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Payments For Repurchase Of Common Stock | 587000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Stockholders Equity | 42000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005694 | 20240331 | Treasury Stock Value Acquired Cost Method | 587000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
| 0001999371-25-005694 | 20241231 | Additional Paid In Capital Common Stock | 61955000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 36000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Common Stock Shares Issued | 4173675.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Common Stock Value | 42000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Earnings Per Share Basic | 0.2400 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | General And Administrative Expense | 68000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | General And Administrative Expense | 12000.0000 | USD | 1 | us-gaap/2025 | Related Party Transaction= Related Party; | ||
| 0001999371-25-005694 | 20240331 | Interest Income Expense Nonoperating Net | 1436000.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001999371-25-005694 | 20250331 | Net Income Loss | 989000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | |||
| 0001999371-25-005694 | 20250331 | Other Receivables Net Current | 111401000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Other Receivables Net Current | 111401000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Pillar; | ||
| 0001999371-25-005694 | 20250331 | Retained Earnings Accumulated Deficit | 62668000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20231231 | Stockholders Equity | 118078000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Stockholders Equity | 61955000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001999371-25-005694 | 20240331 | Stockholders Equity | 42000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001999371-25-005694 | 20241231 | Stockholders Equity | 61679000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20241231 | Stockholders Equity | -1749000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
| 0001999371-25-005694 | 20240331 | Treasury Stock Value Acquired Cost Method | 587000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Treasury Stock Value Acquired Cost Method | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005694 | 20240331 | Treasury Stock Value Acquired Cost Method | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001999371-25-005694 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Common Stock Shares Outstanding | 4066178.0000 | shares | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Advisory Fee To Related Party | 27000.0000 | USD | 1 | 0001999371-25-005694 | |||
| 0001999371-25-005694 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 71000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Common Stock Value | 42000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Costs And Expenses | 95000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Earnings Per Share Basic | 0.2900 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | General And Administrative Expense | 66000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Increase Decrease In Accounts Payable | 3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Increase Decrease In Notes Receivable Related Parties | -102000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Interest Receivable Current | 291000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Net Income Loss | 1178000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001999371-25-005694 | 20241231 | Notes And Loans Receivable Net Noncurrent | 11146000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Operating Income Loss | -95000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Revenues | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005694 | 20240331 | Stockholders Equity | -1534000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
| 0001999371-25-005694 | 20250331 | Treasury Stock Value | 1749000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Treasury Stock Value Acquired Cost Method | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001999371-25-005694 | 20250331 | Assets Current | 111775000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Increase Decrease In Accounts Receivable Related Parties | 731000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Interest Receivable Current | 218000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Liabilities And Stockholders Equity | 121927000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20240331 | Net Cash Provided By Used In Financing Activities | -587000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Revenues | USD | 1 | us-gaap/2025 | ||||
| 0001999371-25-005694 | 20231231 | Stockholders Equity | 57028000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001999371-25-005694 | 20241231 | Stockholders Equity | 121927000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20250331 | Stockholders Equity | 122916000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001999371-25-005694 | 20241231 | Treasury Stock Common Shares | 107497.0000 | shares | 0 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Increase Decrease In Notes Receivable Related Parties | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Notes Receivable, Related Parties | The increase (decrease) during the reporting period in the amount owed to the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Payments For Repurchase Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Interest Income Expense Nonoperating Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Other Receivables Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Receivables, Net, Current | Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Interest Receivable Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Interest Receivable, Current | Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Treasury Stock Common Shares | us-gaap/2025 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Treasury Stock Value Acquired Cost Method | us-gaap/2025 | 0 | 0 | monetary | D | D | Treasury Stock, Value, Acquired, Cost Method | Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Advisory Fee To Related Party | 0001999371-25-005694 | 1 | 0 | monetary | D | D | Advisory fee to related party | The amount of advisory fees to related parties, during the period. |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Treasury Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Costs And Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Increase Decrease In Accounts Receivable Related Parties | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable, Related Parties | The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence. |
| Notes And Loans Receivable Net Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Financing Receivable, after Allowance for Credit Loss, Noncurrent | Amount, after allowance for credit loss, of financing receivable, classified as noncurrent. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001999371-25-005694 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001999371-25-005694 | 2 | 4 | BS | 0 | H | Interest Receivable Current | us-gaap/2025 | Interest receivable from related parties | 0 |
| 0001999371-25-005694 | 2 | 5 | BS | 0 | H | Other Receivables Net Current | us-gaap/2025 | Receivable from related parties | 0 |
| 0001999371-25-005694 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001999371-25-005694 | 2 | 8 | BS | 0 | H | Notes And Loans Receivable Net Noncurrent | us-gaap/2025 | Notes receivable from related parties | 0 |
| 0001999371-25-005694 | 2 | 9 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001999371-25-005694 | 2 | 12 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001999371-25-005694 | 2 | 14 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.01 par value, 10,000,000 shares authorized; 4,173,675 shares issued and 4,066,178 shares outstanding. | 0 |
| 0001999371-25-005694 | 2 | 15 | BS | 0 | H | Treasury Stock Value | us-gaap/2025 | Treasury stock at cost, 107,497 shares. | 1 |
| 0001999371-25-005694 | 2 | 16 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001999371-25-005694 | 2 | 17 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Retained earnings | 0 |
| 0001999371-25-005694 | 2 | 18 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total shareholders equity | 0 |
| 0001999371-25-005694 | 2 | 19 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and equity | 0 |
| 0001999371-25-005694 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
| 0001999371-25-005694 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, authorized | 0 |
| 0001999371-25-005694 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, issued | 0 |
| 0001999371-25-005694 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, outstanding | 0 |
| 0001999371-25-005694 | 3 | 5 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2025 | Treasury stock | 0 |
| 0001999371-25-005694 | 4 | 2 | IS | 0 | H | Revenues | us-gaap/2025 | Other income | 0 |
| 0001999371-25-005694 | 4 | 4 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative (including $12 for the three months ended March 31, 2025 and 2024, from related parties) | 0 |
| 0001999371-25-005694 | 4 | 5 | IS | 0 | H | Advisory Fee To Related Party | 0001999371-25-005694 | Advisory fee to related party | 0 |
| 0001999371-25-005694 | 4 | 6 | IS | 0 | H | Costs And Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001999371-25-005694 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Net operating loss | 0 |
| 0001999371-25-005694 | 4 | 8 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2025 | Interest income from related parties | 0 |
| 0001999371-25-005694 | 4 | 9 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Income tax provision | 1 |
| 0001999371-25-005694 | 4 | 10 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001999371-25-005694 | 4 | 11 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Earnings per share - basic | 0 |
| 0001999371-25-005694 | 4 | 12 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Earnings per share - diluted | 0 |
| 0001999371-25-005694 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average common shares used in computing basic earnings per share | 0 |
| 0001999371-25-005694 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted average common shares used in computing diluted earnings per share | 0 |
| 0001999371-25-005694 | 5 | 6 | IS | 1 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001999371-25-005694 | 6 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Beginning balance, value | 0 |
| 0001999371-25-005694 | 6 | 10 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001999371-25-005694 | 6 | 11 | EQ | 0 | H | Treasury Stock Value Acquired Cost Method | us-gaap/2025 | Repurchase of common shares | 1 |
| 0001999371-25-005694 | 6 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Ending balance, value | 0 |
| 0001999371-25-005694 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001999371-25-005694 | 7 | 4 | CF | 0 | H | Increase Decrease In Notes Receivable Related Parties | us-gaap/2025 | Accrued interest on related party notes receivable | 1 |
| 0001999371-25-005694 | 7 | 5 | CF | 0 | H | Increase Decrease In Accounts Receivable Related Parties | us-gaap/2025 | Related party receivables | 1 |
| 0001999371-25-005694 | 7 | 6 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001999371-25-005694 | 7 | 7 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash provided by operating activities | 0 |
| 0001999371-25-005694 | 7 | 9 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2025 | Repurchase of common shares | 1 |
| 0001999371-25-005694 | 7 | 10 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash used in financing activities | 0 |
| 0001999371-25-005694 | 7 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0001999371-25-005694 | 7 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents, beginning of the period | 0 |
| 0001999371-25-005694 | 7 | 13 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents, end of the period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |